Dr. Frank is internationally recognized for the development and testing of a series of somatic and psychosocial treatment approaches for major depression and bipolar disorder. She has now turned her full attention to the development and deployment of scalable, smartphone-based methods for evaluating and treating behavioral disorders.
Current role
Co-founder & Chief Scientific Officer at Inato
Co-Founder & Chief Scientific Officer at Praxis Medicines
Co-Founder & Chief Scientific Officer at Earli
Co-Founder & Chief Scientific Officer at Synthace
Co-Founder & Chief Scientific Officer at Co-D Therapeutics